United Imaging Intelligence

United Imaging Intelligence (UII), established in December 2017, is the artificial intelligence subsidiary of the United Imaging Group. The company is headquartered in Shanghai, with a significant presence in Boston, Massachusetts, positioning itself at the intersection of global AI talent. UII operates as a developer of AI systems geared towards optimizing clinical diagnostics and medical workflows.

The company's business model is centered on providing AI-powered software solutions that integrate across the entire healthcare continuum. This includes enabling intelligent medical equipment, supporting biomedical research, and offering comprehensive tools for screening, diagnosis, treatment, and follow-up. UII serves a diverse client base, ranging from large tertiary hospitals to county-level hospitals and health centers. Revenue is generated through these AI solutions that enhance diagnostic accuracy, streamline operations, and support precision medicine initiatives. The company has secured significant financial backing, including a Series A funding round of approximately $139.1 million, to accelerate the integration of large language models into clinical settings. This round was co-led by E Fund Management and Shanghai Sitoco Assets Management, with participation from parent company United Imaging Healthcare Technology Group, which remains the largest shareholder.

UII's product portfolio is extensive, featuring over 100 AI applications and more than 10 AI platforms. A key offering is the uAI PLUS platform, a foundational model for medical AI that integrates Medical Imaging Foundation Models and Large Language Models (LLMs). Specific products include uAI AVATAR, an intelligent medical assistant that streamlines patient interactions, and uAI MERITS, a surgical platform that assists with preoperative planning and intraoperative navigation. These solutions are designed to be embedded across a full portfolio of medical imaging equipment, covering modalities like CT, MRI, and PET/CT. A notable achievement is the development of a Deep Learning model for the automated reconstruction of Chronic Total Occlusion (CTO) in coronary arteries, which significantly reduces quantification time compared to manual methods. UII's solutions have been deployed in over 3,000 hospitals internationally, with numerous products receiving clearance from the FDA in the U.S., CE marking in Europe, and NMPA certification in China.

Keywords: medical AI, clinical diagnostics, medical imaging software, healthcare AI solutions, diagnostic imaging, workflow optimization, precision medicine, radiology AI, biomedical research support, large language models in healthcare, uAI platform, computer-aided diagnosis, surgical navigation, PET/CT AI, MRI AI, intelligent medical equipment, clinical decision support, healthcare data analysis, medical image analysis, digital pathology